Checkpoint Kinase 1 Inhibitor Combined with Low Dose Hydroxyurea Promotes ATM-Activated NF-κB-Dependent Pro-Inflammatory Chemokine Expression in Melanomas

Authors

Institutions

Publication Details

Journal
Cancers
Published
2025-05-29
DOI
https://doi.org/10.3390/cancers17111817
Primary Topic
Melanoma and MAPK Pathways
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Checkpoint Kinase 1 Inhibitor Combined with Low Dose Hydroxyurea Promotes ATM-Activated NF-κB-Dependent Pro-Inflammatory Chemokine Expression in Melanomas

Ken‐Hong Lim, Brian Gabrielli, Sherman Ong, Anastasia Gandini et al.
Cancers
Melanoma and MAPK Pathways
article

Checkpoint Kinase 1 Inhibitor Combined with Low Dose Hydroxyurea Promotes ATM-Activated NF-κB-Dependent Pro-Inflammatory Chemokine Expression in Melanomas

Ken‐Hong Lim, Brian Gabrielli, Sherman Ong, Anastasia Gandini, Snehlata Kumari, Zhen Zeng, Rituparna Bhatt, Nicole Lisa Li-Ann Goh, Nur Jannah Abdul Rahim
article en

Abstract

No abstract available for this paper.
CancersVol. 17(11)
The University of Queensland (AU), Mater Research (AU)
Melanoma Research Alliance, Mater Foundation
Openalex Percentile: Top 89%
Melanoma and MAPK Pathways
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.